Orchestra BioMed Holdings (OBIO) Total Current Liabilities (2020 - 2026)

Orchestra BioMed Holdings (OBIO) has 7 years of Total Current Liabilities data on file, last reported at $13.7 million in Q1 2026.

• On a quarterly basis, Total Current Liabilities fell 11.6% year-over-year to $13.7 million in Q1 2026; TTM through Mar 2026 was $13.7 million, a 11.6% decrease from a year earlier, with the FY2025 full-year figure at $16.7 million, up 3.26% from the prior year.
• Total Current Liabilities for Q1 2026 stood at $13.7 million, down from $16.7 million in the prior quarter.
• Over the last five years, Total Current Liabilities for OBIO reached as high as $21.5 million in Q3 2023 and fell as low as $306538.0 in Q1 2022.
• Historically, Total Current Liabilities has averaged $12.9 million across 5 years, with a median of $14.5 million in 2024.
• Across the five-year window, Total Current Liabilities surged 11115.48% in 2022 and slumped 39.63% in 2023, its largest moves.
• Year by year, Total Current Liabilities stood at $18.6 million in 2022, then slumped by 39.63% to $11.2 million in 2023, then soared by 44.6% to $16.2 million in 2024, then climbed by 3.26% to $16.7 million in 2025, then fell by 18.19% to $13.7 million in 2026.
• Per Business Quant data, the three most recent Total Current Liabilities figures were $13.7 million in Q1 2026, $16.7 million in Q4 2025, and $20.7 million in Q3 2025.